JP2025527471A5 - - Google Patents
Info
- Publication number
- JP2025527471A5 JP2025527471A5 JP2025508431A JP2025508431A JP2025527471A5 JP 2025527471 A5 JP2025527471 A5 JP 2025527471A5 JP 2025508431 A JP2025508431 A JP 2025508431A JP 2025508431 A JP2025508431 A JP 2025508431A JP 2025527471 A5 JP2025527471 A5 JP 2025527471A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- caprate
- crystalline form
- therapeutically effective
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263371690P | 2022-08-17 | 2022-08-17 | |
| US63/371,690 | 2022-08-17 | ||
| US202263384298P | 2022-11-18 | 2022-11-18 | |
| US63/384,298 | 2022-11-18 | ||
| PCT/US2023/072326 WO2024040125A1 (en) | 2022-08-17 | 2023-08-16 | Crystalline forms of a pcsk9 inhibitor, compositions and uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025527471A JP2025527471A (ja) | 2025-08-22 |
| JP2025527471A5 true JP2025527471A5 (enExample) | 2025-12-23 |
| JP7866141B2 JP7866141B2 (ja) | 2026-05-26 |
Family
ID=89942405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025508431A Active JP7866141B2 (ja) | 2022-08-17 | 2023-08-16 | Ｐｃｓｋ９阻害薬の結晶形態、組成物及び使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20260035411A1 (enExample) |
| EP (1) | EP4573104A4 (enExample) |
| JP (1) | JP7866141B2 (enExample) |
| KR (1) | KR20250048468A (enExample) |
| CN (1) | CN119731194A (enExample) |
| AU (1) | AU2023325144A1 (enExample) |
| CO (1) | CO2025001998A2 (enExample) |
| IL (1) | IL319006A (enExample) |
| MX (1) | MX2025001887A (enExample) |
| WO (1) | WO2024040125A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026032253A1 (zh) * | 2024-08-06 | 2026-02-12 | 石药集团中奇制药技术（石家庄）有限公司 | 环肽类似物及其制备方法和用途 |
| WO2026101894A1 (en) * | 2024-11-07 | 2026-05-15 | Merck Sharp & Dohme Llc | Process for preparing a peptide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250161677A (ko) | 2018-06-21 | 2025-11-17 | 머크 샤프 앤드 돔 엘엘씨 | Pcsk9 길항제 화합물 |
| EP3810129B1 (en) | 2018-06-21 | 2023-08-16 | Merck Sharp & Dohme LLC | Pcsk9 antagonist bicyclo-compounds |
| WO2019246405A1 (en) | 2018-06-21 | 2019-12-26 | Merck Sharp & Dohme Corp. | Cyclic polypeptides for pcsk9 inhibition |
| EP4021919A1 (en) * | 2019-08-30 | 2022-07-06 | Merck Sharp & Dohme Corp. | Pcsk9 antagonist compounds |
-
2023
- 2023-08-16 JP JP2025508431A patent/JP7866141B2/ja active Active
- 2023-08-16 WO PCT/US2023/072326 patent/WO2024040125A1/en not_active Ceased
- 2023-08-16 EP EP23855649.2A patent/EP4573104A4/en active Pending
- 2023-08-16 IL IL319006A patent/IL319006A/en unknown
- 2023-08-16 US US19/100,813 patent/US20260035411A1/en active Pending
- 2023-08-16 KR KR1020257008518A patent/KR20250048468A/ko active Pending
- 2023-08-16 AU AU2023325144A patent/AU2023325144A1/en active Pending
- 2023-08-16 CN CN202380059715.1A patent/CN119731194A/zh active Pending
-
2025
- 2025-02-14 MX MX2025001887A patent/MX2025001887A/es unknown
- 2025-02-25 CO CONC2025/0001998A patent/CO2025001998A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022536979A5 (enExample) | ||
| US20220370366A1 (en) | Tablets containing cilofexor and pharmaceutically acceptable carriers | |
| CN102395276A (zh) | 硝唑尼特的控制释放药物剂型 | |
| JPWO2023027198A5 (enExample) | ||
| US10745415B2 (en) | Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations | |
| EP2797584B1 (en) | Combinations of diacerein and non-steroidal inflammation drugs | |
| US20080200549A1 (en) | Pharmaceutical composition of ibuprofen and paracetamol and methods of using the same | |
| JP7774958B2 (ja) | 二層医薬錠剤製剤 | |
| HU228149B1 (en) | Film coated tablet of paracetamol and domperidone | |
| JP2024507810A5 (enExample) | ||
| JP2024544538A5 (enExample) | ||
| JP2019218379A5 (enExample) | ||
| JP2023528896A5 (enExample) | ||
| CN101296696A (zh) | 一种用于治疗痛风的药物组合物及其制备方法和用途 | |
| JP2025508098A5 (enExample) | ||
| JP2022518288A5 (enExample) | ||
| JP3982889B2 (ja) | イブプロフェン含有医薬製剤 | |
| KR102022694B1 (ko) | 약학 조성물 | |
| WO2020089761A1 (en) | Pharmaceutical composition comprising of remogliflozin or salt or ester thereof and vildagliptin or salt thereof | |
| JP4153124B2 (ja) | 鎮痛剤 | |
| WO2011081118A1 (ja) | 経口投与用医薬組成物 | |
| JP2024532129A5 (enExample) | ||
| NZ193239A (en) | Anti-inflammatory compositions containing 1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid and a 2-hydroxy-5-halophenylbenzoic acid derivative | |
| EP1121124A1 (en) | Pharmaceutical combination of ibuprofen-lysine and domperidone for treating migraine | |
| JP7506475B2 (ja) | フェブキソスタット製剤 |